Alfa Aesar™ Ceftiofur sodium, 95%
A broad spectrum antibiotic
Manufacturer: Alfa Aesar™ J6688606
Ceftiofur sodium; 95%; Powder; Alfa Aesar; 5g; FW: 545.54g/mol; C19H16N5NaO7S3; CAS: 104010-37-9Applications
Ceftiofur sodium is resistant to the antibiotic resistance enzyme beta-lactamase, and has activity against Gram-positive and Gram-negative bacteria. E. coli strains resistant to ceftiofur have been reported. The bactericidal activity of ceftiofur results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins. The PBPs are transpeptidases which are vital in peptidoglycan biosynthesis. Therefore, their inhibition prevents this vital cell wall component from being properly synthesized.
Freely soluble in aqueous solution
Research Use only: Not intended for animal or human diagnostic or therapeutic use.
|Freely soluble in aqueous solution|
|Off-white or yellow|
Safety and Handling
SDS & Safety Documents
GHS H Statement
May cause allergy or asthma symptoms or breathing difficulties if inhaled.
May cause an allergic skin reaction.
GHS P Statement
In case of inadequate ventilation wear respiratory protection.
Avoid breathing dust/fume/gas/mist/vapors/spray.
Wear protective gloves/protective clothing/eye protection/face protection.
If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
Wash contaminated clothing before reuse.
Dispose of contents/container in accordance with local/regional/national/international regulations.
RTECSNumber : XI0367360
storageNote1 : 2° to 8°C